Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses

Medical Mycology

Volumn 38, Issue , 2000, Pages 161-171

  Verweij, P E ^a   Figueroa, J ^b   Van Burik, J ^c   Holdom, M D ^b   Dei Cas, E ^d   Gomez B L ^b,e   Mendes Giannini, M J ^f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d INSTITUT PASTEUR DE LILLE   (France)

^e Institut Pasteur de Lille ^*  (Colombia)

^f SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antigenemia; Molecular analyses; Nonculture diagnosis; PCR diagnosis

Indexed keywords

ATOVAQUONE; COPPER ZINC SUPEROXIDE DISMUTASE; FUNGUS ANTIGEN; MONOCLONAL ANTIBODY; SULFANILAMIDE DERIVATIVE;

ANTIBODY RESPONSE; ANTIGEN DETECTION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE LIBRARY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; IMMUNOCOMPETENCE; MOLECULAR GENETICS; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SEROLOGY; SOUTH AMERICAN BLASTOMYCOSIS;

ANTIGENS, FUNGAL; CULTURE MEDIA; DNA, FUNGAL; ENDEMIC DISEASES; HUMANS; MITOSPORIC FUNGI; MYCOSES; OPPORTUNISTIC INFECTIONS; POLYMERASE CHAIN REACTION;

AJELLOMYCES CAPSULATUS; ASPERGILLUS FUMIGATUS; FUNGI; PARACOCCIDIOIDES BRASILIENSIS; PNEUMOCYSTIS CARINII;

EID: 0034508469     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.38.s1.161.171     Document Type: Article

References (100)

1. Natural history of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
2. The detection of Aspergillus spp. By the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid
3. Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction
4. Detection of Aspergillus fumigatus by polymerase chain reaction
5. General primer-mediated PCR for detection of Aspergillus species
6. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR
7. Detection and identification of fungal pathogens in blood by using molecular probes
8. Detection of a wide range of medically important fungi by the polymerase chain reaction
9. Panfungal PCR assay for detection of fungal infection in human blood specimens
10. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis
11. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction
12. Comparison of antigen detection and PCR assay with bronchoalveolar lavage fluid for diagnosing invasive aspergillosis in patients receiving treatment for hematological malignancies
13. Aspergillus fumigatus and aspergillosis
14. Fungal infections in cancer patients: An international autopsy survey
15. Fungal infections in patients with acute leukemia
16. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients
17. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis
18. The 18-kilodalton antigen secreted by Aspergillus fumigatus
19. Biochemical and antigenic characterization of a new dipeptidyl-peptidase isolated from Aspergillus fumigatus
20. Cell wall antigens in Aspergillus fumigatus
21. An immunodominant 90-kilodalton Aspergillus fumigatus antigen is the subunit of a catalase
22. Purification, N-terminal amino acid sequence and partial characterization of a Cu-Zn superoxide dismutase from the pathogenic fungus Aspergillus fumigatus
23. The Cu-Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: Purification and biochemical comparison with the Aspergillus fumigatus Cu-Zn superoxide dismutase
24. Specific recognition of purified Cu-Zn superoxide dismutase from Aspergillus fumigatus by immune human sera
25. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus
26. Production and characterization of recombinant Aspergillus fumigatus Cu-Zn superoxide dismutase and its recognition by immune human sera
27. Expression of the Cu-Zn superoxide dismutase of Aspergillus fumigatus as determined by immunochemistry and immunoelectron microscopy
28. Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family
29. Molecular genetics of superoxide dismutases in yeasts and related fungi
30. Structure, exon pattern and chromosome mapping of the gene for cytosolic copper-zinc superoxide dismutase (sod-1) from Neurospora crassa
31. Pneumocystis carinii, un défi pour le biologiste
32. Detection of Pneumocystis carinii with DNA amplification
33. Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction
34. Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia
35. Potential impact of Pneumocystis genetic diversity on the molecular detection of the parasite in human host
36. Pneumocystis carinii detection in 158 HIV-seronegative patients
37. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from HIV-infected patients: Use of a simple DNA extraction procedure and nested polymerase chain reaction
38. Laboratory diagnosis of Pneumocystis carinii infections by PCR directed to genes encoding for mitochondrial 5S and 28S ribosomal RNA
39. Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: A blinded comparison to standard methods
40. Oropharyngeal samples for detection of Pneumocystis carinii by DNA amplification
41. Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes
42. Diagnosis of Pneumocystis carinii pneumonia: Immunofluorescence staining, simple PCR or nPCR
43. Orophatyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia
44. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples
45. Detection of Pneumocystis carinii DNA in blood specimens from human immunodificiency virus-infected patients by nested PCR
46. Detection of Pneumocystis carinii DNA in blood by PCR is not of value for diagnosis of P. Carinii pneumonia
47. Comparison of six different PCR methods for detection of Pneumocystis carinii
48. Extraordinary low number of ribosomal RNA genes in P. Carinii
49. Pneumocystis carinii genotypes and severity of pneumonia
50. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. Carinii pneumonia
51. Drug-resistant Pneumocystis carinii
52. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapson use
53. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure
54. A search for Pneumocystis carinii in post-mortem lungs by DNA amplification
55. High frequency of Pneumocystis carinii f. Sp. Carinii colonization in HIV-negative patients
56. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients
57. Pulmonary colonization with Pneumocystis carinii in Human Immunodeficiency Virus-negative patients: Assessing risk with blood CD4+ T cell counts
58. Pneumocystis carinii infection in patients with chronic bronchial disease
59. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR
60. Carriage of Pneumocystis carinii in children with chronic lung diseases
61. DNA amplification in experimental pneumocystosis: Characterization of serum Pneumocystis carinii DNA and potential Pneumocystis carinii carrier states
62. Latency is not an inevitable outcome of infection with Pneumocystis carinii
63. Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. Carinii pneumonia
64. Immunocompetent contacts of Pneumocystis carinii-infected-hosts can potentially transmit the disease to susceptible hosts
65. Noninvasive methods for the diagnosis of pneumonia
66. A search of Pneumocystis carinii DNA by the polymerase chain reaction on bronchoalveolar lavage fluids from patients with Wegener granulomatosis
67. Serodiagnosis of histoplasmosis, paracoccid-ioidomycosis and penicilliosis marnefeld; current status and trends
68. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens
69. The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children
70. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis
71. Histoplasmosis in the acquired immunodeficiency syndrome
72. Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis and treatment, and review of the literature
73. Significance of Histoplasma antigen in the cerebroespinal fluid of patients with meningitis
74. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid
75. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis
76. Monoclonal antibodies for the detection of Histoplasma capsulatum variety capsulatum antigens in patients with histoplasmosis
77. Comparison of sandwich solid-phase radioimmunoassay and two enzyme-linked immunosorbent assays for detection of Histoplasma capsulatum polysaccharide antigen
78. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for the detection of Histoplasma capsulatum var. Capsulatum antigen
79. Cross-reactivity in the Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycosis
80. Development of a novel antigen detection test for histoplasmosis
81. The detection of the 70-kDa Histoplasma capsulatum antigen in serum of histoplasmosis patients: Correlation between antigenaemia and therapy during the course of follow up
82. Serodiagnosis
83. Report of activities of the committee on paracoccidioidomycosis serodiagnosis
84. IgG, IgM and IgA antibody response for the diagnosis and follow up of paracoccidioidomycosis: Comparison of counter-immunoelectrophoresis and complement fixation
85. Cloning, characterization and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis
86. Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in sero-diagnosis of paracoccidioidomycosis
87. Identification of antigenic polypeptides of Paracoccidioides brasiliensis by immunoblotting
88. Antibody response to the 43 kDa glycoprotein of Paracoccidioides brasiliensis as a marker of evaluation of patients under treatment
89. Antigenemia in paracoccidioidomycosis. Probable demonstration of circulating antigen by counterimmunoelectrophoresis test
90. Detection of paracoccidioidomycosis circulating antigens by immunoelectrophoresis - Immunodiffusion technique. Preliminary report
91. Antigenemia in paracoccidioidomycosis
92. Use of monoclonal antibodies in diagnosis of paracoccidioidomycosis: New strategies for detection of circulating antigens
93. Antigenemia in patients with paracoccidioidomycosis: Detection of the 87-kilo-dalton determinant during and after antifungal therapy
94. Detection of the 43.000 molecular weight glycoprotein in sera of patients with paracoccidioidomycosis
95. Study of antigenemia and antigenuria in paracoccidioidomycosis in relation to specific antibodies
96. Detection of circulating Paracoccidioides brasiliensis antigen in urine of paracoccidioidomycosis patients before and during treatment
97. Treatment and control of cure